Experimental brain cancer therapy seeks to control deadly tumor growth
Disease control
Recruiting now
This early-stage trial is testing whether a new drug called RZ-001, when combined with an existing antiviral medication (valganciclovir), can help control glioblastoma, an aggressive brain cancer. The study will first determine safe doses and then see if the treatment shows signs…
Phase: PHASE1, PHASE2 • Sponsor: Rznomics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC